JS Series SterilContainer S2 System
FDA Device Recall #Z-0624-2018 — Class II — September 8, 2017
Recall Summary
| Recall Number | Z-0624-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 8, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Aesculap Implant Systems LLC |
| Location | Center Valley, PA |
| Product Type | Devices |
| Quantity | 292 units |
Product Description
JS Series SterilContainer S2 System
Reason for Recall
The JS Series SterilContainer S2 System was released to the market place prior to an authorized FDA 510K clearance. No other Aesculap SterilContainer System products are impacted by this recall.
Distribution Pattern
Nationally
Lot / Code Information
JS440 S2 1/1CONT.BOTTON PERFOR.H88MM H202 JS441 S2 1/1 CONT.BOTTOMPERFOR.H1118MM H202 JS442 S2 1/1-CONT.BOTTOM PERFOR.H133MM H202 JS444 S2 1/1 CONT.BOTTOM PEFOR.H185MM H202 JS489 S2 1/1-CONTAINER LID H202 JS740 S2 3/4 CONT.BOTTOM PERFOR.H88MMH202 JS741 S2 3/4 CONT.BOTTOM PERFOR.H118MM H202 JS742 S2 3/4 CONT.BOTTOM PERFOR.H133MM H202 JS789 S2 3/4 CONTAINER LID H202 JS340 S2 1/2 CONT.BOTTOM PERFOR.H88MM H202 JS341 S2 1/2 CONT.BOTTOM PERFOR.H118MM H202 JS342 S2 1/2 CONT.BOTTOM PERFOR.H133MM H202 JS389 S2 1/2 CONTAINER LID H202
Other Recalls from Aesculap Implant Systems LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2518-2023 | Class II | For intraventricular indications mainly used fo... | Jul 20, 2023 |
| Z-2146-2023 | Class II | Aesculap Surgical Needle, straight, 3 1/2", (90... | May 18, 2023 |
| Z-1569-2023 | Class II | Aesculap Caiman Articulating D5/360MM - An elec... | Mar 21, 2023 |
| Z-1430-2023 | Class II | Caspar Cervical Retractor (CCR) Basket ME754 - ... | Feb 23, 2023 |
| Z-1638-2022 | Class II | Aesculap ENNOVATE SET SCREW STERILE-implants ar... | Jul 15, 2022 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.